Michael Eide, MD
Ophthalmology · Sioux Falls, SDNPI 1710152061
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 50 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by AbbVie at 32.9% of the total. That places this record below the midpoint for ophthalmology clinicians in SD, where the typical reported total is $1,431.
Across 50 payments — averaging $20.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$335
- Alcon$161
- Amgen$84
- Glaukos Corporation$69
- Tarsus Pharmaceuticals, Inc.$64
- Alimera Sciences, Inc.$48
- plus $256 from 9 others
What the payments were for
- Food & beverage$1,017100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 17 | $335 |
| Alcon | 9 | $161 |
| Amgen | 5 | $84 |
| Glaukos Corporation | 1 | $69 |
| Tarsus Pharmaceuticals, Inc. | 3 | $64 |
| Alimera Sciences, Inc. | 2 | $48 |
| Bausch & Lomb Americas Inc. | 3 | $48 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $34 |
| Apellis Pharmaceuticals, Inc. | 2 | $34 |
| Biotissue Holdings Inc. | 2 | $34 |
| The Cameron-ehlen Group, Inc. | 1 | $28 |
| Rxsight Inc | 1 | $25 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $23 |
| Sun Pharmaceutical Industries Inc. | 1 | $18 |
| Aerie Pharmaceuticals, Inc. | 1 | $11 |
How this compares
$1,017 in reported general payments places this provider in the 45th percentile of 52 ophthalmology providers in South Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 32 | $32,002 |
| Prednisolone Acetate | 865 | $25,542 |
| Ofloxacin | 680 | $7,854 |
| Fluorometholone | 54 | $3,854 |
| ValacyclovirValacyclovir Hcl | 125 | $3,747 |
| Loteprednol Etabonate | 27 | $3,216 |
| MoxifloxacinMoxifloxacin Hcl | 47 | $1,398 |
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 22 | $1,029 |
| Latanoprost | 95 | $1,028 |
| ErythromycinErythromycin Base | 88 | $1,026 |
| Timolol Maleate | 47 | $872 |
| Ketorolac Tromethamine | 73 | $825 |
| Acyclovir | 43 | $680 |
| Doxycycline Hyclate | 18 | $486 |
| Brimonidine Tartrate | 23 | $402 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis | $335 | $32,00232 claims |
| Bausch & Lomb, A Division Of Bausch Health US, LLCLoteprednol Etabonate | $23 | $3,21627 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 52 ophthalmology providers in South Dakota.
Other ophthalmology in Sioux Falls
- Vance ThompsonSioux Falls$1.9M
- John BerdahlSioux Falls$1.2M
- Daniel TerveenSioux Falls$521K
- Tanner FergusonSioux Falls$49K
- Alison TendlerSioux Falls$31K
- Brent KramerSioux Falls$26K
- Jed AssamSioux Falls$18K
- Anthony MaiSioux Falls$8K
- Ryan GeraetsSioux Falls$7K
- Eric ThomasSioux Falls$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.